Search results
Results from the WOW.Com Content Network
In April 2017, Neuralink announced that it was aiming to make devices to treat serious brain diseases in the short term, with the eventual goal of human enhancement, sometimes called transhumanism. [ 22 ] [ 10 ] [ 23 ] Musk said his interest in the idea partly stemmed from the concept of " neural lace " in the fictional universe in The Culture ...
In 2016, Musk launched Neuralink with help from seven scientists and one engineer. Only two remain of the founding group—Musk and engineer DJ Seo. The goal of Neuralink is to develop brain ...
Noland Arbaugh (born 1993 or 1994) is an American quadriplegic known for being the first human recipient of Neuralink's brain-computer interface (BCI) implant. [1] He gained attention for his use of the device to regain digital autonomy after a spinal cord injury left him paralyzed.
Neuralink, which first tested its device in monkeys and other animals, is now testing the device in humans. The company makes a brain-chip which enables paralyzed patients to control a computer ...
This is a timeline of the development of prophylactic human vaccines. Early vaccines may be listed by the first year of development or testing, but later entries usually show the year the vaccine finished trials and became available on the market. Although vaccines exist for the diseases listed below, only smallpox has
According to Elon Musk, the first human received an implant from his computer-brain interface company Neuralink over the weekend. In a Monday post on X, the platform formerly known as Twitter ...
Neuralink released a nine-minute video in which its first human patient, who is paralyzed below his shoulders, appears to move a cursor across a laptop screen with nothing but his thoughts.
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases.